Minimal PD-1 expression in mouse and human NK cells under diverse conditions-Reference-Cited by-同舟云学术

Minimal PD-1 expression in mouse and human NK cells under diverse conditions

Published:2020-05-11 Issue:6 Volume:130 Page:3051-3068
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Judge Sean J.^ORCID,Dunai Cordelia^ORCID,Aguilar Ethan G.^ORCID,Vick Sarah C.,Sturgill Ian R.^ORCID,Khuat Lam T.,Stoffel Kevin M.,Van Dyke Jonathan,Longo Dan L.,Darrow Morgan A.,Anderson Stephen K.^ORCID,Blazar Bruce R.,Monjazeb Arta M.,Serody Jonathan S.^ORCID,Canter Robert J.^ORCID,Murphy William J.

Funder

NIH, Robert Lambert Family Fund, NCI

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/133353/files/pdf

Reference75 articles.

1. The future of immune checkpoint therapy

2. Molecular and cellular insights into T cell exhaustion

3. CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions

4. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protocol to study the immune profile of syngeneic mouse tumor models;STAR Protocols;2024-09

2. TIGIT: Will it be the next star therapeutic target like PD-1 in hematological malignancies?;Critical Reviews in Oncology/Hematology;2024-09

3. Defects in NK cell immunity of pediatric cancer patients revealed by deep immune profiling;iScience;2024-09

4. Tumor-induced natural killer cell dysfunction is a rapid and reversible process uncoupled from the expression of immune checkpoints;Science Advances;2024-08-30

5. In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors;OncoImmunology;2024-07-18